VLA2001

VLA2001 · Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VLA2001, covering 2021-12-02 to 2023-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years [Phase 3]